Bone remodeling markers: assessment of fracture risk and fracture risk reduction.

Abstract:

:There is an increasing repertoire of laboratory tests available for assessing the bone remodeling process. Biochemical markers of bone remodeling can be measured in serum or urine, and have a number of potential roles in the management of fracture risk. Differences in remodeling between individuals might be related to fracture risk and could be used to target therapy. Change in remodeling with therapy could be related to fracture risk reduction and the choice of therapy could be influenced by knowledge of bone remodeling. Biochemical therapeutic monitoring may improve patient understanding and therapeutic adherence. The rate of bone remodeling is weakly predictive of fracture risk in individuals who are not receiving therapy; however, it is not clear whether this is independent of other risk factors. There is increasing evidence that change in bone mineral density does not explain fracture risk reduction with antiresorptive therapies, and that therapeutic benefit might be explained by change in bone turnover. Additional studies and information are required to allow these scientific advances to be translated into cost-effective and validated clinical protocols. Optimizing the precision and accuracy of bone turnover assessment remains an important priority.

journal_name

Curr Osteoporos Rep

authors

Blumsohn A

doi

10.1007/s11914-996-0002-9

keywords:

subject

Has Abstract

pub_date

2003-12-01 00:00:00

pages

91-7

issue

3

eissn

1544-1873

issn

1544-2241

journal_volume

1

pub_type

杂志文章,评审
  • Cellular Processes by Which Osteoblasts and Osteocytes Control Bone Mineral Deposition and Maturation Revealed by Stage-Specific EphrinB2 Knockdown.

    abstract:PURPOSE OF REVIEW:We outline the diverse processes contributing to bone mineralization and bone matrix maturation by describing two mouse models with bone strength defects caused by restricted deletion of the receptor tyrosine kinase ligand EphrinB2. RECENT FINDINGS:Stage-specific EphrinB2 deletion differs in its effe...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-019-00524-y

    authors: Blank M,Sims NA

    更新日期:2019-10-01 00:00:00

  • The Skeletal Consequences of Bariatric Surgery.

    abstract:PURPOSE OF REVIEW:This review outlines the recent findings regarding the impact of bariatric surgery on bone. It explores potential mechanisms for skeletal changes following bariatric surgery and strategies for management. RECENT FINDINGS:Bone loss following bariatric surgery is multifactorial. Probable mechanisms inc...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-020-00579-2

    authors: Krez AN,Stein EM

    更新日期:2020-06-01 00:00:00

  • Denosumab: an Emerging Therapy in Pediatric Bone Disorders.

    abstract:PURPOSE OF REVIEW:Denosumab is an inhibitor of receptor activator of nuclear factor kappa-B ligand (RANKL), and has emerged as an important novel therapy for skeletal disorders. This article examines the use of denosumab in children. RECENT FINDINGS:Considerable safety and efficacy data exists for denosumab treatment ...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-017-0380-1

    authors: Boyce AM

    更新日期:2017-08-01 00:00:00

  • Combining high-resolution micro-computed tomography with material composition to define the quality of bone tissue.

    abstract::Atraumatic fractures of the skeleton in osteoporotic patients are directly related to a deterioration of bone strength. However, the failure of the bone tissue to withstand functional load bearing cannot be explained as a simple decrease in bone mineral density (quantity); strength is also significantly dependent upon...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-003-0003-x

    authors: Judex S,Boyd S,Qin YX,Miller L,Müller R,Rubin C

    更新日期:2003-06-01 00:00:00

  • Ex vivo Bone Models and Their Potential in Preclinical Evaluation.

    abstract:PURPOSE OF REVIEW:Novel therapies for damaged and diseased bone are being developed in a preclinical testing process consisting of in vitro cell experiments followed by in vivo animal studies. The in vitro results are often not representative of the results observed in vivo. This could be caused by the complexity of th...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-020-00649-5

    authors: Cramer EEA,Ito K,Hofmann S

    更新日期:2021-01-11 00:00:00

  • New Developments in Fracture Risk Assessment for Current Osteoporosis Reports.

    abstract:PURPOSE OF REVIEW:Identifying individuals at high fracture risk can be used to target those likely to derive the greatest benefit from treatment. This narrative review examines recent developments in using specific risk factors used to assess fracture risk, with a focus on publications in the last 3 years. RECENT FIND...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-020-00590-7

    authors: Leslie WD,Morin SN

    更新日期:2020-06-01 00:00:00

  • RNA-seq in Skeletal Biology.

    abstract:PURPOSE OF REVIEW:The goal of this paper is to review state-of-the-art transcriptome profiling methods and their recent applications in the field of skeletal biology. RECENT FINDINGS:Next-generation sequencing of mRNA (RNA-seq) methods have been established and routinely used in skeletal biology research. RNA-seq has ...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-019-00517-x

    authors: Ayturk U

    更新日期:2019-08-01 00:00:00

  • Statistical shape and appearance models in osteoporosis.

    abstract::Statistical models (SMs) of shape (SSM) and appearance (SAM) have been acquiring popularity in medical image analysis since they were introduced in the early 1990s. They have been primarily used for segmentation, but they are also a powerful tool for 3D reconstruction and classification. All these tasks may be require...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-014-0206-3

    authors: Castro-Mateos I,Pozo JM,Cootes TF,Wilkinson JM,Eastell R,Frangi AF

    更新日期:2014-06-01 00:00:00

  • Stem cell interactions in a bone marrow niche.

    abstract::Stem cells differ from other cells of the body in their potential for multilineage differentiation and their continued proliferation without substantial loss of potential (so-called self-renewal). These properties are maintained and regulated by a specific microenvironment referred to as "niche." This term has been us...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-011-0075-y

    authors: Isern J,Méndez-Ferrer S

    更新日期:2011-12-01 00:00:00

  • Orthobiologics in the augmentation of osteoporotic fractures.

    abstract::Many orthobiologic adjuvants are available and widely utilized for general skeletal restoration. Their use for the specific task of osteoporotic fracture augmentation is less well recognized. Common conductive materials are reviewed for their value in this patient population including the large group of allograft adju...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-014-0249-5

    authors: Watson JT,Nicolaou DA

    更新日期:2015-02-01 00:00:00

  • The RANKL/RANK/OPG pathway.

    abstract::Understanding of osteoclast formation and activation has advanced considerably since the discovery of the RANKL/RANK/OPG system in the mid 1990s. Osteoblasts and stromal stem cells express receptor activator of NF-jB ligand (RANKL), which binds to its receptor, RANK, on the surface of osteoclasts and their precursors....

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章

    doi:10.1007/s11914-007-0024-y

    authors: Boyce BF,Xing L

    更新日期:2007-09-01 00:00:00

  • Is it ethical to use placebos in osteoporosis clinical trials?

    abstract::Because there are now effective agents for treatment of osteoporosis, the question is being raised as to whether or not it is ethical to have placebo-controlled trials of new agents. It is ethical for patients who are at low risk of serious or irreversible harm to participate in placebo-controlled trials as long as th...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-004-0012-4

    authors: Watts NB

    更新日期:2004-03-01 00:00:00

  • The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy.

    abstract::Microbial biofilms have been observed and described in bone specimens of patients with bisphosphonate (BP)-associated osteonecrosis of the jaw (BONJ) and investigators are more recently suggesting that this condition essentially represents an osteomyelitis of the jaw clinically, with greater susceptibility in some pat...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章

    doi:10.1007/s11914-010-0008-1

    authors: Kumar SK,Gorur A,Schaudinn C,Shuler CF,Costerton JW,Sedghizadeh PP

    更新日期:2010-03-01 00:00:00

  • Diabetes and Bone Marrow Adiposity.

    abstract:PURPOSE OF REVIEW:This study aims to describe bone marrow fat changes in diabetes and to discuss the potential role of marrow fat in skeletal fragility. RECENT FINDINGS:Advances in non-invasive imaging have facilitated marrow fat research in humans. In contrast to animal studies which clearly demonstrate higher levels...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-016-0336-x

    authors: Kim TY,Schafer AL

    更新日期:2016-12-01 00:00:00

  • Calcium supplementation: is protecting against osteoporosis counter to protecting against cardiovascular disease?

    abstract::Calcium is the dominant mineral in bone and is a shortfall nutrient in the diet. For those consuming inadequate dietary calcium, calcium supplements have been a standard strategy for prevention of osteoporosis. Recently, calcium supplementation has been linked to both increased and decreased cardiovascular disease ris...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-014-0208-1

    authors: Weaver CM

    更新日期:2014-06-01 00:00:00

  • Romosozumab: a Review of Efficacy, Safety, and Cardiovascular Risk.

    abstract:PURPOSE OF REVIEW:Authors review the safety and efficacy of romosozumab for the treatment of osteoporosis as demonstrated in three phase III clinical trials and offer insights into the potential cardiovascular risk associated with its use. RECENT FINDINGS:Incidence of new vertebral fracture is dramatically reduced wit...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-020-00652-w

    authors: Fixen C,Tunoa J

    更新日期:2021-01-07 00:00:00

  • Influence of hormonal appetite and energy regulators on bone.

    abstract::Nutritional status is an essential component in determining whole body energy homeostasis. The balance between energy/food intake and metabolism is governed by a range of hormones secreted from various parts of the body. Their subsequent dissemination via the blood results in a wide range of biological responses inclu...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-013-0157-0

    authors: Khor EC,Wee NK,Baldock PA

    更新日期:2013-09-01 00:00:00

  • Augmentation of implant fixation in osteoporotic bone.

    abstract::Osteoporosis presents a dilemma for the orthopedic surgeon. Screw fixation within the bone is crucial for mechanical stabilization, maintenance of reduction, and ultimately, fracture healing. For the patient, soft bones and physiological fragility usually benefit from immediate weight bearing and mobility to avoid fur...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章

    doi:10.1007/s11914-012-0124-1

    authors: Jones CB

    更新日期:2012-12-01 00:00:00

  • Osteocyte-Mediated Translation of Mechanical Stimuli to Cellular Signaling and Its Role in Bone and Non-bone-Related Clinical Complications.

    abstract:PURPOSE OF REVIEW:Osteocytes comprise > 95% of the cellular component in bone tissue and produce a wide range of cytokines and cellular signaling molecules in response to mechanical stimuli. In this review, we aimed to summarize the molecular mechanisms involved in the osteocyte-mediated translation of mechanical stimu...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-020-00564-9

    authors: Yan Y,Wang L,Ge L,Pathak JL

    更新日期:2020-02-01 00:00:00

  • Therapies for musculoskeletal disease: can we treat two birds with one stone?

    abstract::Musculoskeletal diseases are highly prevalent with staggering annual health care costs across the globe. The combined wasting of muscle (sarcopenia) and bone (osteoporosis)-both in normal aging and pathologic states-can lead to vastly compounded risk for fracture in patients. Until now, our therapeutic approach to the...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-014-0204-5

    authors: Girgis CM,Mokbel N,Digirolamo DJ

    更新日期:2014-06-01 00:00:00

  • Evaluation and correction of low vitamin D status.

    abstract::Low vitamin D status, which is endemic due to inadequate oral intake combined with sun avoidance, contributes to musculoskeletal and other pathologies. Although controversial, it is increasingly recommended that serum 25-hydroxyvitamin D (25D) concentrations less than 30 ng/mL be considered suboptimal. Clinicians shou...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-008-0017-5

    authors: Binkley N,Krueger D

    更新日期:2008-09-01 00:00:00

  • Bone cells and bone turnover in diabetes mellitus.

    abstract::Substantial evidence exists that in addition to the well-known complications of diabetes, increased fracture risk is an important morbidity. This risk is probably due, at least in part, to altered bone remodeling and bone cell function in diabetes. Circulating biochemical markers of bone formation, including P1NP, ost...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章

    doi:10.1007/s11914-015-0265-0

    authors: Rubin MR

    更新日期:2015-06-01 00:00:00

  • In Vivo Osteocyte Mechanotransduction: Recent Developments and Future Directions.

    abstract:PURPOSE OF REVIEW:Mechanical loading is an essential stimulus for skeletal tissues. Osteocytes are primarily responsible for sensing mechanical stimuli in bone and for orchestrating subsequent responses. This is critical for maintaining homeostasis, and responding to injury/disease. The osteocyte mechanotransduction pa...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-018-0485-1

    authors: Hinton PV,Rackard SM,Kennedy OD

    更新日期:2018-12-01 00:00:00

  • Anorexia, bulimia, and the athletic triad: evaluation and management.

    abstract::Caloric restriction caused by undernutrition or over-exercise is increasingly common and has significant health consequences such as hypothalamic amenorrhea, infertility, attainment of low peak bone mass, and bone loss leading to fracture. In these patients, the pathophysiology of amenorrhea and bone loss is multifact...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-007-0011-3

    authors: Fenichel RM,Warren MP

    更新日期:2007-12-01 00:00:00

  • Vitamin D Activity and Metabolism in Bone.

    abstract:PURPOSE OF REVIEW:In addition to the actions of the endocrine hormone, 1alpha,25-dihydroxyvitamin D (1,25(OH)2D) in stimulating intestinal calcium absorption, the regulation of bone mineral metabolism by 1,25(OH)2D is also considered an important contributor to calcium homeostasis. However, recent evidence suggest that...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-017-0394-8

    authors: Anderson PH

    更新日期:2017-10-01 00:00:00

  • Defective skeletal mineralization in pediatric CKD.

    abstract::Although traditional diagnosis and treatment of renal osteodystrophy focused on changes in bone turnover, current data demonstrate that abnormalities in skeletal mineralization are also prevalent in pediatric chronic kidney disease (CKD) and likely contribute to skeletal morbidities that continue to plague this popula...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-015-0253-4

    authors: Wesseling-Perry K

    更新日期:2015-04-01 00:00:00

  • Vitamin D and immune function: understanding common pathways.

    abstract::Vitamin D, acting through its active metabolite 1,25(OH)(2)D(3), exerts its influence on many physiologic processes in addition to the regulation of calcium and phosphate homeostasis. These processes include the immune system. Both the adaptive and innate immune systems are affected by 1,25(OH)(2)D(3) and its receptor...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章

    doi:10.1007/s11914-009-0011-6

    authors: Bikle DD

    更新日期:2009-07-01 00:00:00

  • Epidemiology and pathophysiology of osteoporosis in men.

    abstract::Osteoporosis in men is an unrecognized but growing problem as the number of men who live to old age increases. The 10-year fracture risk at age 50 quadruples by age 80, and in general the incidence rate of osteoporotic fracture in men is about half that of women. Of note, the mortality and morbidity after hip fracture...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-996-0030-5

    authors: Adler RA

    更新日期:2006-09-01 00:00:00

  • Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

    abstract::Metabolic bone disease is a major public health concern, especially when it manifests as hip fracture which carries significant morbidity and mortality. Individuals with neurological disease are at higher risk of osteopenia, osteoporosis and fragility fracture compared to age-matched controls, yet this is under-apprec...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-016-0320-5

    authors: Binks S,Dobson R

    更新日期:2016-10-01 00:00:00

  • Bone mineral density deficits and fractures in survivors of childhood cancer.

    abstract::Although substantial increases in survival rates among children diagnosed with cancer have been observed in recent decades, survivors are at risk of developing therapy-related chronic health conditions. Among children and adolescents treated for cancer, acquisition of peak bone mass may be compromised by cancer therap...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-013-0165-0

    authors: Wilson CL,Ness KK

    更新日期:2013-12-01 00:00:00